The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Primary Biliary Cirrhosis Drug Revenue 1.5 Market Analysis by Type 1.5.1 Global Primary Biliary Cirrhosis Drug Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Budesonide 1.5.3 FFP-104 1.5.4 GSK-2330672 1.5.5 MBX-8025 1.5.6 NGM-282 1.5.7 Others 1.6 Market by Application 1.6.1 Global Primary Biliary Cirrhosis Drug Market Share by Application: 2021-2026 1.6.2 Clinic 1.6.3 Hospital 1.6.4 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Primary Biliary Cirrhosis Drug Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Primary Biliary Cirrhosis Drug Market Players Profiles 3.1 AlbireoPharma 3.1.1 AlbireoPharma Company Profile 3.1.2 AlbireoPharma Primary Biliary Cirrhosis Drug Product Specification 3.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 MediGene AG 3.2.1 MediGene AG Company Profile 3.2.2 MediGene AG Primary Biliary Cirrhosis Drug Product Specification 3.2.3 MediGene AG Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Enanta Pharmaceuticals, Inc. 3.3.1 Enanta Pharmaceuticals, Inc. Company Profile 3.3.2 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Specification 3.3.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 CymaBay Therapeutics, Inc. 3.4.1 CymaBay Therapeutics, Inc. Company Profile 3.4.2 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Specification 3.4.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Johnson & Johnson 3.5.1 Johnson & Johnson Company Profile 3.5.2 Johnson & Johnson Primary Biliary Cirrhosis Drug Product Specification 3.5.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Dr. Falk Pharma GmbH 3.6.1 Dr. Falk Pharma GmbH Company Profile 3.6.2 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Specification 3.6.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Virobay Inc. 3.7.1 Virobay Inc. Company Profile 3.7.2 Virobay Inc. Primary Biliary Cirrhosis Drug Product Specification 3.7.3 Virobay Inc. Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Intercept Pharmaceuticals, Inc. 3.8.1 Intercept Pharmaceuticals, Inc. Company Profile 3.8.2 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Specification 3.8.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 GlaxoSmithKline Plc 3.9.1 GlaxoSmithKline Plc Company Profile 3.9.2 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Specification 3.9.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 NGM Biopharmaceuticals, Inc. 3.10.1 NGM Biopharmaceuticals, Inc. Company Profile 3.10.2 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Specification 3.10.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Primary Biliary Cirrhosis Drug Market Competition by Market Players 4.1 Global Primary Biliary Cirrhosis Drug Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Market Players (2015-2020) 4.3 Global Primary Biliary Cirrhosis Drug Average Price by Market Players (2015-2020) 5 Global Primary Biliary Cirrhosis Drug Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.1.2 Primary Biliary Cirrhosis Drug Key Players in North America (2015-2020) 5.1.3 North America Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.1.4 North America Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.2.2 Primary Biliary Cirrhosis Drug Key Players in East Asia (2015-2020) 5.2.3 East Asia Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.2.4 East Asia Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.3.2 Primary Biliary Cirrhosis Drug Key Players in Europe (2015-2020) 5.3.3 Europe Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.3.4 Europe Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.4.2 Primary Biliary Cirrhosis Drug Key Players in South Asia (2015-2020) 5.4.3 South Asia Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.4.4 South Asia Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.5.2 Primary Biliary Cirrhosis Drug Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.5.4 Southeast Asia Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.6.2 Primary Biliary Cirrhosis Drug Key Players in Middle East (2015-2020) 5.6.3 Middle East Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.6.4 Middle East Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.7.2 Primary Biliary Cirrhosis Drug Key Players in Africa (2015-2020) 5.7.3 Africa Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.7.4 Africa Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.8.2 Primary Biliary Cirrhosis Drug Key Players in Oceania (2015-2020) 5.8.3 Oceania Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.8.4 Oceania Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.9.2 Primary Biliary Cirrhosis Drug Key Players in South America (2015-2020) 5.9.3 South America Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.9.4 South America Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Primary Biliary Cirrhosis Drug Market Size (2015-2020) 5.10.2 Primary Biliary Cirrhosis Drug Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Primary Biliary Cirrhosis Drug Market Size by Type (2015-2020) 5.10.4 Rest of the World Primary Biliary Cirrhosis Drug Market Size by Application (2015-2020) 6 Global Primary Biliary Cirrhosis Drug Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Primary Biliary Cirrhosis Drug Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Primary Biliary Cirrhosis Drug Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Primary Biliary Cirrhosis Drug Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Primary Biliary Cirrhosis Drug Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Primary Biliary Cirrhosis Drug Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Primary Biliary Cirrhosis Drug Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Primary Biliary Cirrhosis Drug Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Primary Biliary Cirrhosis Drug Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Primary Biliary Cirrhosis Drug Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Primary Biliary Cirrhosis Drug Consumption by Countries 7 Global Primary Biliary Cirrhosis Drug Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Primary Biliary Cirrhosis Drug (2021-2026) 7.2 Global Forecasted Revenue of Primary Biliary Cirrhosis Drug (2021-2026) 7.3 Global Forecasted Price of Primary Biliary Cirrhosis Drug (2021-2026) 7.4 Global Forecasted Production of Primary Biliary Cirrhosis Drug by Region (2021-2026) 7.4.1 North America Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.3 Europe Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.7 Africa Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.9 South America Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Primary Biliary Cirrhosis Drug Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Primary Biliary Cirrhosis Drug by Application (2021-2026) 8 Global Primary Biliary Cirrhosis Drug Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.2 East Asia Market Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.3 Europe Market Forecasted Consumption of Primary Biliary Cirrhosis Drug by Countriy 8.4 South Asia Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.5 Southeast Asia Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.6 Middle East Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.7 Africa Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.8 Oceania Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.9 South America Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 8.10 Rest of the world Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country 9 Global Primary Biliary Cirrhosis Drug Sales by Type (2015-2026) 9.1 Global Primary Biliary Cirrhosis Drug Historic Market Size by Type (2015-2020) 9.2 Global Primary Biliary Cirrhosis Drug Forecasted Market Size by Type (2021-2026) 10 Global Primary Biliary Cirrhosis Drug Consumption by Application (2015-2026) 10.1 Global Primary Biliary Cirrhosis Drug Historic Market Size by Application (2015-2020) 10.2 Global Primary Biliary Cirrhosis Drug Forecasted Market Size by Application (2021-2026) 11 Global Primary Biliary Cirrhosis Drug Manufacturing Cost Analysis 11.1 Primary Biliary Cirrhosis Drug Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug 12 Global Primary Biliary Cirrhosis Drug Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Primary Biliary Cirrhosis Drug Distributors List 12.3 Primary Biliary Cirrhosis Drug Customers 12.4 Primary Biliary Cirrhosis Drug Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 139 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 200 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 254 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 250 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 143 |
We will be happy to help you find what you need. Please call us or write to us: